Nations Financial Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,646
Closed -$2.17M 827
2026
Q1
$2.17M Sell
9,646
-101
-1% -$25.2K 0.11% 208
2025
Q4
$2.35M Buy
9,747
+219
+2% +$56K 0.12% 186
2025
Q3
$2.61M Buy
9,528
+95
+1% +$25.9K 0.16% 151
2025
Q2
$2.43M Sell
9,433
-1
-0% -$239 0.17% 150
2025
Q1
$2.11M Buy
9,434
+706
+8% +$165K 0.16% 157
2024
Q4
$2M Buy
+8,728
New +$2.1M 0.15% 174
2021
Q1
Sell
-2,944
Closed -$626K 363
2020
Q4
$626K Sell
2,944
-16
-0.5% -$3.19K 0.16% 165
2020
Q3
$507K Buy
2,960
+13
+0.4% +$2.4K 0.16% 171
2020
Q2
$566K Buy
+2,947
New +$482K 0.2% 148

Other funds holding RMD

Nations Financial Group's RMD Position: Q2 2026 in Review

Nations Financial Group sold out of ResMed (RMD) in Q2 2026, closing a stake of 9,646 shares — an estimated $2.17M sold.

Nations Financial Group first reported a position in RMD in Q2 2020 and held it in 9 quarters. The position peaked at $2.61M in Q3 2025. 192 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Nations Financial Group reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Nations Financial Group sold 9,646 ResMed shares in Q2 2026, an estimated $2.17M.
  • Nations Financial Group first reported a position in ResMed in Q2 2020 and held it in 9 quarters.
  • Nations Financial Group's ResMed position peaked at $2.61M in Q3 2025.
  • 192 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.